Matheson R T, Miller D R, Lacombe M J, Han Y N, Iwanaga S, Kato H, wuepper K D
J Clin Invest. 1976 Dec;58(6):1395-406. doi: 10.1172/JCI108595.
Flaujeac trait is the functional deficiency of a plasma protein of the intrinsic coagulation, kinin-forming, and plasma fibrinolytic pathways. The Flaujeac factor in man has been isolated and tentatively identified as a kininogen of high molecular weight (HMW). Highly purified bovine HMW-kininogen, but not bovine low molecular weight kininogen, repaired Flaujeac factor deficiency. The two subspecies of this molecule, HMW-kininogen a and HMW-kininogen b, also corrected Flaujeac factor deficiency. When bovine HMW-kininogen was incubated with bovine plasma kallikrein, kinin-free HMW-kininogen, bradykinin, and a glycopeptide fragment (peptide 1-2; 12,584 daltons) were rapidly released. None of these fragmentation products corrected Flaujeac factor deficiency alone or in mixtures. The function of HMW-kininogen appeared to depend upon the structural integrity of the native molecule. When injected in concentrations of 2 pmol-8 nmol/0.1 ml, peptide 1-2 caused increased vascular permeability in rabbits, rats, or guinea pigs. The enhanced permeability was maximal within 1-2 min and terminated in 5-10 min, differing from that of bradykinin or histamine. Injected together in equimolar amounts, peptide 1-2 and bradykinin produced a synergistic permeability response which was immediate in onset as well as prolonged in duration. Peptide 1-2 is a rapidly acting, highly basic glyco-peptide which mediates increased vascular permeability in a complementary and synergistic manner with bradykinin.
弗洛热克性状是内源性凝血、激肽形成和血浆纤维蛋白溶解途径中一种血浆蛋白的功能缺陷。人类的弗洛热克因子已被分离出来,并初步鉴定为高分子量(HMW)激肽原。高度纯化的牛HMW-激肽原可修复弗洛热克因子缺乏症,而牛低分子量激肽原则不能。该分子的两个亚种,即HMW-激肽原a和HMW-激肽原b,也能纠正弗洛热克因子缺乏症。当牛HMW-激肽原与牛血浆激肽释放酶一起孵育时,无激肽的HMW-激肽原、缓激肽和一个糖肽片段(肽1-2;12,584道尔顿)会迅速释放。这些片段产物单独或混合使用时均不能纠正弗洛热克因子缺乏症。HMW-激肽原的功能似乎取决于天然分子的结构完整性。当以2 pmol-8 nmol/0.1 ml的浓度注射时,肽1-2会导致兔、大鼠或豚鼠的血管通透性增加。增强的通透性在1-2分钟内达到最大值,并在5-10分钟内终止,这与缓激肽或组胺不同。以等摩尔量一起注射时,肽1-2和缓激肽会产生协同的通透性反应,起效迅速且持续时间延长。肽1-2是一种作用迅速、碱性很强的糖肽,它与缓激肽以互补和协同的方式介导血管通透性增加。